\-\ Texto\\:\\ \ \(0\)\
\-\ general\\:\\ the\\ patient\\ is\\ a\\ white\\ male\\.\\ he\\ is\\ 170\\.2cm\\ tall\\ and\\ weighs\\ about\\ 98\\.7\\ kg\\ \\(bmi\\ 34\\.1\\)\\.\\ blood\\ pressure\\ on\\ the\\ left\\ arm\\ in\\ the\\ seated\\ position\\ is\\ 129\\/64\\.\\ appears\\ stated\\ age\\.\\ he\\ is\\ well\\ appearing\\ and\\ in\\ no\\ acute\\ distress\\.\ \(0\)\
\-\ heent\\ \\:\\ normocephalic\\,\\ non\\ traumatic\\.\\ pupils\\ were\\ equal\\ and\\ reactive\\ to\\ light\\.\\ \ \(0\)\
\-\ cardiac\\:\\ regular\\ rate\\ and\\ rhythm\\,\\ normal\\ s1\\ and\\ s2\\.\\ no\\ murmurs\\,\\ rubs\\,\\ or\\ gallops\\.\\ right\\ sided\\ scars\\ visible\\ from\\ healed\\ vats\\.\\ median\\ sternotomy\\ incision\\ is\\ well\\ healed\\.\\ \ \(0\)\
\-\ pulmonary\\ \\:\\ pattern\\ unlabored\\,\\ breath\\ sounds\\ are\\ clear\\ and\\ equal\\ bilaterally\\,\\ no\\ distress\\.\\ no\\ rales\\,\\ no\\ rhonchi\\,\\ no\\ wheezez\\.\ \(0\)\
\-\ abdomen\\:\\ non\\-distended\ \(0\)\
\-\ extremities\\:\\ no\\ cyanosis\\,\\ no\\ clubbing\\,\\ no\\ edema\\,\\ no\\ coolness\\ and\\ no\\ deformities\\.\\ \ \(0\)\
\-\ musculoskeletal\\:\\ 5\\+\\ muslce\\ strength\\ in\\ all\\ extremities\\,\\ gait\\ and\\ tone\\ are\\ normal\\.\ \(0\)\
\-\ this\\ patient\\ was\\ initially\\ treated\\ with\\ right\\ thoracotomy\\,\\ which\\ yielded\\ 2l\\ of\\ fluid\\.\\ this\\ procedure\\ significantly\\ improved\\ his\\ shortness\\ of\\ breath\\.\\ \ \(0\)\
\-\ he\\ then\\ underwent\\ a\\ right\\ vats\\ pleurectomy\\ and\\ was\\ then\\ referred\\ to\\ outpatient\\ an\\ outpatient\\ medical\\ oncologist\\ who\\ is\\ currently\\ managing\\ his\\ treatment\\.\ \(0\)\
\-\ he\\ currently\\ on\\ chemotherapy\\ under\\ supervision\\ of\\ a\\ medical\\ oncologist\\,\\ and\\ reports\\ that\\ he\\ is\\ doing\\ well\\.\ \(0\)\
\-\ images\\ 1\\ and\\ 2\\ represent\\ a\\ pre\\-operative\\ pet\\-ct\\.\\ the\\ patient\\ was\\ given\\ iv\\ 18f\\-fdg\\ followed\\ by\\ low\\-dose\\,\\ non\\ contrast\\ ct\\ from\\ the\\ skull\\ vertex\\ to\\ the\\ mid\\-thigh\\.\\ this\\ ct\\ was\\ obtained\\ for\\ attenuation\\ correction\\ and\\ anatomic\\ orientation\\ with\\ axial\\ reconstruction\\.\\ pet\\ followed\\,\\ encompassing\\ the\\ same\\ regions\\.\\ the\\ chest\\ was\\ found\\ to\\ show\\ mild\\ to\\ moderate\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleural\\ effusion\\/thickening\\.\\ \\ there\\ was\\ a\\ small\\ internal\\ decrease\\ in\\ size\\.\\ there\\ was\\ no\\ axillary\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ there\\ is\\ no\\ air\\-space\\ disease\\ or\\ suspicious\\ lung\\ nodule\\.\\ these\\ findings\\ are\\ consistent\\ with\\ low\\-grade\\ metabolically\\ active\\ malignant\\ epithelioid\\ neoplasm\\ consistent\\ with\\ mesothelioma\\ of\\ the\\ right\\-sided\\ pleura\\.\\ \ \(0\)\
\-\ image\\ 3\\ represents\\ erect\\ pa\\ and\\ lateral\\ chest\\ images\\ following\\ vats\\ pleurectomy\\.\\ these\\ films\\ demonstrate\\ post\\-sternotomy\\ midline\\ wires\\ and\\ clips\\.\\ of\\ note\\ there\\ is\\ mild\\ to\\ moderate\\ cardiomegaly\\ and\\ chronic\\ right\\ basolateral\\ pleural\\ thickening\\ of\\ the\\ inferior\\ right\\ minor\\ fissure\\.\\ a\\ mediport\\-type\\ catheter\\ is\\ visualized\\ overlying\\ the\\ superior\\ right\\ hemithorax\\ with\\ its\\ distal\\ extent\\ projecting\\ over\\ the\\ course\\ of\\ the\\ right\\ jugular\\ vein\\.\\ there\\ is\\ also\\ minor\\ bronchitis\\ interstitial\\ features\\ at\\ the\\ lung\\ bases\\.\\ there\\ is\\ no\\ acute\\ pathology\\ noted\\,\\ and\\ there\\ is\\ no\\ evidence\\ of\\ pneumothorax\\ or\\ definitive\\ infiltrates\\.\ \(0\)\
\-\ image\\ 4\\ represents\\ a\\ follow\\ up\\ study\\ approximately\\ 2\\ weeks\\ after\\ image\\ 3\\ was\\ obtained\\.\\ there\\ was\\ evidence\\ of\\ copd\\.\\ it\\ was\\ noted\\ that\\ there\\ was\\ pleural\\-parenchymal\\ scarring\\ of\\ the\\ right\\ lung\\ base\\.\\ the\\ same\\ medial\\ sternotomy\\ changes\\ were\\ noted\\,\\ as\\ was\\ the\\ mediport\\ placement\\ and\\ cardiomegaly\\.\\ at\\ this\\ point\\ there\\ was\\ no\\ active\\ pulmonary\\ disease\\ noted\\.\\ \ \(0\)\
\-\ images\\ 5\\,\\ 6\\,\\ and\\ 7\\ represent\\ post\\-operative\\ pet\\-ct\\ following\\ right\\-sided\\ vats\\ pleurectomy\\.\\ the\\ same\\ protocol\\ was\\ followed\\ as\\ for\\ the\\ pet\\-ct\\ shown\\ in\\ images\\ 1\\ and\\ 2\\.\\ there\\ was\\ found\\ to\\ be\\ minimal\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleura\\.\\ there\\ was\\ no\\ axillary\\,\\ supraclavicular\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ the\\ image\\ has\\ the\\ overall\\ appearance\\ of\\ postsurgical\\ inflammatory\\ changes\\,\\ although\\ residual\\ low\\-grade\\ metabolically\\ active\\ metastasis\\ cannot\\ be\\ excluded\\.\ \(0\)\
\-\ malignant\\ mesothelioma\\,\\ epithelioid\\ type\ \(0\)\
\-\ asbestosis\ \(10\)\
\-\ malignant\\ mesothelioma\ \(14\)\
\-\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ male\\ who\\ presented\\ to\\ his\\ primary\\ care\\ physician\\ as\\ part\\ of\\ a\\ pre\\-operative\\ work\\-up\\ for\\ cataract\\ surgery\\.\\ on\\ cxr\\ it\\ was\\ noted\\ that\\ the\\ patient\\ has\\ a\\ pleural\\ effusion\\.\\ the\\ patient\\ did\\ note\\ that\\ he\\ had\\ increasing\\ shortness\\ of\\ breath\\,\\ but\\ did\\ not\\ think\\ to\\ address\\ this\\ issue\\ prior\\ to\\ his\\ pre\\-op\\ clearance\\.\\ \ \(0\)\
\-\ pmhx\\:\\ \ \(0\)\
\-\ gerd\\,\\ gout\\,\\ hyperlipidemia\\,\\ benign\\ tumor\\ of\\ colon\\,\\ osteoarthritis\\,\\ rheumatic\\ fever\\,\\ htn\\,\\ congestive\\ heart\\ failure\\,\\ cad\\,\\ myocardial\\ infarction\ \(0\)\
\-\ pshx\\:\\ \ \(0\)\
\-\ neck\\ surgery\\ in\\ childhood\\ \\(ages\\ 5\\ and\\ 10\\)\\,\\ cholecystecomy\\ s\\/p\\ gallbladder\\ rupture\\,\\ quadruple\\ bypass\\ surgery\\,\\ hemicolectomy\\,\\ avulsed\\ fingers\\,\\ vats\\,\\ right\\ pleurectomy\ \(0\)\
\-\ medications\\:\\ almethicone\\ 125mg\\,\\ albuterol\\-ipratropium\\,\\ oxycodone\\ 10mg\\,\\ senna\\ oral\\,\\ tamsulosin\\,\\ alprazolam\\,\\ isosorbide\\ mononitrate\\,\\ plavix\\,\\ aspirin\\,\\ lipitor\\,\\ allopurinol\\,\\ atenolol\\,\\ ranitidine\\,\\ fluoxetine\\,\\ nitroglycerin\\,\\ ferrous\\ sulfate\\.\\ \ \(0\)\
\-\ allergies\\:\\ adhesive\\ tape\\ \\(rash\\)\ \(0\)\
\-\ transfusions\\:\\ the\\ patient\\ has\\ had\\ 2\\ blood\\ transfusions\\ as\\ a\\ result\\ of\\ rectal\\ bleeding\\ from\\ gi\\ tumors\\.\ \(0\)\
\-\ social\\:\\ 34\\ pack\\ year\\ smoking\\ histroy\\ \\(2\\ ppd\\ for\\ 17\\ years\\)\\,\\ quit\\ smoking\\ in\\ 1970\\.\\ history\\ of\\ alcohol\\ abuse\\,\\ sober\\ since\\ 2012\\ when\\ he\\ underwent\\ treatment\\ for\\ etoh\\ withdrawal\\.\\ he\\ denies\\ any\\ illicit\\ and\\/or\\ iv\\ drug\\ abuse\\.\\ \\ the\\ patient\\ has\\ 3\\ children\\.\\ he\\ lives\\ in\\ an\\ apartment\\ on\\ his\\ house\\,\\ which\\ his\\ daughter\\ occupies\\.\\ he\\ worked\\ as\\ at\\ chemical\\ plant\\ for\\ 40\\ years\\.\\ he\\ recalls\\ this\\ plant\\ is\\ adjacent\\ to\\ another\\ chemical\\ plant\\ which\\ used\\ asbestos\\ as\\ part\\ of\\ its\\ plastics\\ manufacturing\\ process\\.\ \(0\)\
\-\ nathan\\ kronenwetter\\,\\ ms\\ iv\\;\\ frank\\ mascaro\\,\\ md\\;\\ randall\\ loftus\\,\\ md\\;\\ joanna\\ garvey\\,\\ dc\\;\\ robert\\ lutnick\\,\\ md\\;\\ scott\\ croce\\,\\ dc\\;\\ gary\\ smith\\,\\ dc\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\,\\ md\\,\\ vaseem\\ iqbal\\,\\ md\\;\\ jennifer\\ sperrazza\\,\\ dc\\;\\ jeffrey\\ lieberman\\,\\ md\\;\\ geoffrey\\ gerow\\,\\ dc\\.\\ \\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ white\\ male\\.\\ he\\ worked\\ in\\ a\\ factory\\ adject\\ to\\ a\\ chemical\\ plant\\,\\ which\\ used\\ asbestos\\ in\\ the\\ manufacturing\\ of\\ plastic\\ products\\.\\ he\\ states\\ that\\ he\\ remembers\\ hearing\\ that\\ during\\ the\\ day\\,\\ the\\ plant\\ would\\ vacuum\\ excess\\ asbestos\\ from\\ the\\ factory\\ floor\\ to\\ the\\ roof\\ of\\ the\\ building\\ and\\ then\\ vent\\ the\\ asbestos\\ out\\ the\\ stacks\\ of\\ the\\ factory\\ at\\ night\\.\\ in\\ fact\\,\\ the\\ patient\\'s\\ grown\\ son\\,\\ now\\ in\\ his\\ fifties\\,\\ recalls\\ there\\ often\\ being\\ a\\ thin\\ coating\\ of\\ \\?dust\\?\\ on\\ park\\ benches\\ in\\ the\\ morning\\ following\\ the\\ venting\\ from\\ the\\ plant\\.\\ \ \(0\)\
\-\ the\\ patient\\ states\\ that\\ he\\ worked\\ in\\ a\\ plant\\ approximately\\ 600\\ feet\\ from\\ the\\ asbestos\\-using\\ facility\\,\\ and\\ states\\ that\\ his\\ factory\\ was\\ under\\ negative\\ pressure\\,\\ resulting\\ in\\ outside\\ asbestos\\-containing\\ air\\ to\\ be\\ \\?sucked\\ into\\?\\ his\\ factory\\.\\ he\\ began\\ work\\ in\\ the\\ 1960s\\ and\\ worked\\ at\\ the\\ same\\ plant\\ for\\ 41\\ years\\ until\\ his\\ retirement\\ in\\ 2003\\.\\ he\\ also\\ lived\\ approximately\\ 1\\ mile\\ from\\ both\\ plants\\,\\ and\\ states\\ that\\ his\\ home\\ was\\ directly\\ downwind\\ from\\ the\\ factories\\.\\ unfortunately\\,\\ this\\ patient\\ reported\\ that\\ a\\ former\\ coworker\\ died\\ of\\ complications\\ from\\ mesothelioma\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ mesothelioma\\ was\\ discovered\\ incidentally\\ as\\ part\\ of\\ pre\\-operative\\ clearance\\ for\\ a\\ propsed\\ opthalmologic\\ surgery\\.\\ as\\ part\\ of\\ his\\ pre\\-operative\\ work\\-up\\ a\\ chest\\ xray\\ was\\ ordered\\,\\ which\\ revealed\\ a\\ large\\ plueral\\ effusion\\.\\ he\\ recalls\\ that\\ at\\ the\\ time\\ of\\ discovery\\ he\\ did\\ have\\ shortness\\ of\\ breath\\ with\\ minimal\\ exersion\\,\\ stating\\ that\\ he\\ would\\ become\\ short\\ of\\ breath\\ \\?just\\ by\\ talking\\?\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ case\\ is\\ typical\\ of\\ malignant\\ pleural\\ mesothelioma\\.\\ this\\ disease\\ typically\\ affects\\ patients\\ who\\ are\\ 60\\ years\\ and\\ older\\.\\ often\\,\\ these\\ patients\\ present\\ decades\\ after\\ an\\ exposure\\ to\\ asbestos\\ and\\ have\\ gradual\\,\\ worsening\\,\\ nonspecific\\ pulmonary\\ symptoms\\ including\\ but\\ not\\ limited\\ to\\:\\ chest\\ pain\\,\\ dyspnea\\,\\ cough\\,\\ hoarseness\\,\\ or\\ dysphagia\\.\ \(0\)\
\-\ physical\\ findings\\ at\\ the\\ time\\ of\\ diagnosis\\ generally\\ are\\ related\\ to\\ a\\ pleural\\ effusion\\,\\ which\\ is\\ often\\ present\\.\\ physical\\ exam\\ findings\\ may\\ include\\ unilateral\\ dullness\\ to\\ percussion\\ at\\ the\\ lung\\ base\\,\\ decreased\\ air\\ movement\\ on\\ side\\ of\\ involvement\\,\\ or\\ asymmetric\\ chest\\ wall\\ expansion\\ during\\ respiration\\ \\(2\\-6\\)\\.\ \(0\)\
\-\ the\\ primary\\ risk\\ factor\\ for\\ mesothelioma\\ is\\ asbestos\\ exposure\\.\\ the\\ fibers\\ of\\ asbestos\\,\\ a\\ naturally\\ occuring\\ mineral\\,\\ are\\ strong\\ and\\ resistant\\ to\\ heat\\,\\ and\\ have\\ been\\ used\\ in\\ the\\ production\\ of\\ insulation\\,\\ brakes\\,\\ shingles\\,\\ flooring\\ and\\ many\\ other\\ products\\.\\ if\\ asbestos\\ is\\ broken\\ up\\,\\ and\\ the\\ dust\\ is\\ inhaled\\ or\\ swallowed\\,\\ the\\ fibers\\ will\\ settle\\ in\\ the\\ lungs\\,\\ leading\\ to\\ irritation\\,\\ which\\ can\\ then\\ progress\\ to\\ mesothelioma\\.\\ the\\ exact\\ mechanism\\ of\\ this\\ malignant\\ transformation\\ is\\ poorly\\ understood\\.\\ the\\ development\\ of\\ mesothelioma\\ following\\ asbestos\\ exposure\\ may\\ be\\ a\\ \\ 20\\ \\-\\ 40\\ year\\ process\\.\\ of\\ note\\,\\ most\\ people\\ with\\ years\\ of\\ asbestos\\ exposure\\ never\\ develop\\ mesothelioma\\,\\ while\\ some\\ people\\,\\ with\\ only\\ minimal\\ exposure\\,\\ develop\\ the\\ disease\\.\\ given\\ this\\ variation\\,\\ a\\ predisposition\\ to\\ cancer\\ likely\\ plays\\ a\\ role\\ in\\ disease\\ progression\\.\\ additional\\ risk\\ factors\\ include\\,\\ living\\ with\\ someone\\ working\\ with\\ asbestos\\ \\(as\\ they\\ may\\ carry\\ the\\ fibers\\ home\\ on\\ their\\ clothing\\ and\\ skin\\)\\,\\ as\\ well\\ as\\ family\\ history\\ of\\ mesothelioma\\ \\(7\\-\\ 9\\)\\.\ \(0\)\
\-\ in\\ terms\\ of\\ imaging\\,\\ computed\\ tomography\\ \\(ct\\)\\ is\\ often\\ pursued\\ given\\ limited\\ sensitivity\\ and\\ specificity\\ with\\ cxr\\.\\ findings\\ include\\ unilateral\\ pleural\\ abnormalities\\ with\\ a\\ large\\ unilateral\\ pleural\\ effusion\\.\\ there\\ may\\ be\\ a\\ plural\\ mass\\ or\\ \\"rind\\"\\,\\ or\\ even\\ a\\ diffuse\\ pleural\\ thickening\\ in\\ the\\ absence\\ of\\ pleural\\ effusion\\.\\ there\\ can\\ be\\ ipsilateral\\ mediastinal\\ shift\\ due\\ to\\ encasement\\ of\\ the\\ lung\\ by\\ a\\ thick\\ \\"rind\\"of\\ tumor\\ and\\ relative\\ ipsilateral\\ lung\\ volume\\ loss\\.\\ when\\ positron\\ emission\\ tomography\\ \\(pet\\)\\ is\\ used\\ in\\ conjunction\\ with\\ ct\\,\\ \\ increased\\ uptake\\ of\\ fluorodeoxyglucose\\ \\(fdg\\)\\ is\\ observed\\.\ \(0\)\
\-\ for\\ the\\ diagnosis\\ of\\ malignant\\ mesothelioma\\,\\ clinical\\ suspicion\\ may\\ arise\\ with\\ respiratory\\ symptoms\\,\\ pleural\\ thickening\\ and\\/or\\ effusion\\ on\\ chest\\ imaging\\,\\ and\\ a\\ history\\ of\\ asbestos\\ exposure\\.\\ however\\,\\ ultimately\\,\\ a\\ biopsy\\ is\\ necessary\\ to\\ confirm\\ the\\ diagnosis\\.\ \(0\)\
\-\ once\\ diagnosed\\,\\ an\\ integrated\\ positron\\ emission\\ tomography\\ with\\ computed\\ tomography\\ \\(pet\\-ct\\)\\ is\\ the\\ initial\\ staging\\ assessment\\.\ \(0\)\
\-\ when\\ diagnosed\\ at\\ an\\ early\\ stage\\,\\ surgeons\\ may\\ remove\\ the\\ mesothelioma\\,\\ and\\ in\\ some\\ cases\\,\\ this\\ may\\ be\\ curative\\.\\ other\\ therapies\\ include\\ chemotherapy\\ and\\ radiation\\ therapy\\.\\ there\\ are\\ ongoing\\ clinical\\ trials\\ investigating\\ targeted\\ biological\\ and\\ gene\\ therapy\\.\ \(0\)\
\-\ overall\\,\\ however\\,\\ the\\ prognosis\\ is\\ poor\\.\\ the\\ survival\\ is\\ on\\ the\\ spectrum\\ of\\ 9\\ to\\ 17\\ months\\ after\\ diagnosis\\ and\\ few\\ patients\\ are\\ cured\\ \\(12\\)\\.\ \(0\)\
\-\ references\\ for\\ malignant\\ pleural\\ mesothelioma\ \(0\)\
\-\ 1\\.\\ husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ 2\\.\\	socola\\ f\\,\\ loaiza\\-bonilla\\ a\\,\\ bustinza\\-linares\\ e\\,\\ et\\ al\\.\\ recurrent\\ thrombotic\\ thrombocytopenic\\ purpura\\-like\\ syndrome\\ as\\ a\\ paraneoplastic\\ phenomenon\\ \\ in\\ malignant\\ peritoneal\\ mesothelioma\\:\\ a\\ case\\ report\\ and\\ review\\ of\\ the\\ literature\\.\\ case\\ rep\\ oncol\\ med\\ 2012\\;\\ \\ 2012\\:619348\\.\ \(0\)\
\-\ 3\\.\\	wong\\ sf\\,\\ newland\\ l\\,\\ john\\ t\\,\\ white\\ sc\\.\\ paraneoplastic\\ leukocytoclastic\\ vasculitis\\ as\\ an\\ initial\\ presentation\\ \\ of\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ case\\ report\\.\\ j\\ med\\ case\\ rep\\ 2012\\;\\ 6\\:261\\.\ \(0\)\
\-\ 4\\.\\	li\\ jy\\,\\ yong\\ ty\\,\\ kuss\\ bj\\,\\ et\\ al\\.\\ malignant\\ pleural\\ mesothelioma\\ with\\ associated\\ minimal\\ change\\ disease\\ and\\ acute\\ renal\\ \\ failure\\.\\ ren\\ \\ fail\\ 2010\\;\\ 32\\:1012\\.\ \(0\)\
\-\ 5\\.\\	bech\\ c\\,\\ s0rensen\\ jb\\.\\ polyneuropathy\\ \\ in\\ a\\ patient\\ with\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ paraneoplastic\\ \\ syndrome\\.\\ j\\ thorac\\ oncol\\ \\ 2008\\;\\ \\ 3\\:1359\\.\ \(0\)\
\-\ 6\\.\\	tanriverdi\\ 0\\,\\ meydan\\ n\\,\\ barutca\\ s\\,\\ et\\ al\\.\\ anti\\-yo\\ antibody\\-mediated\\ paraneoplastic\\ cerebellar\\ degeneration\\ in\\ a\\ female\\ patient\\ with\\ pleural\\ malignant\\ mesothelioma\\.\\ jpn\\ j\\ clin\\ oncol\\ 2013\\;\\ 43\\:563\\.\ \(0\)\
\-\ 7\\.\\	malignant\\ pleural\\ mesothelioma\\.\\ fort\\ washington\\,\\ pa\\.\\:\\ national\\ comprehensive\\ cancer\\ network\\.\\ http\\:\\/\\/www\\.nccn\\.org\\/professionals\\/physician\\_gls\\/f\\_guidelines\\.asp\\.\\ \\ \\ accessed\\ sept\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 8\\.\\	niederhuber\\ \\ je\\,\\ et\\ al\\.\\,\\ eds\\.\\ diseases\\ of\\ the\\ pleura\\ and\\ mediastinum\\.\\ in\\:\\ abeloff\\ s\\ clinical\\ oncology\\.\\ 5th\\ ed\\.\\ philadelphia\\,\\ pa\\.\\:\\ churchill\\ livingstone\\ elsevier\\;\\ 2014\\.\\ http\\:\\/\\/www\\.clinicalkey\\.com\\.\\ \\ \\ accessed\\ \\ \\ sept\\.\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 9\\.\\	osha\\ fact\\ sheet\\:\\ asbestos\\.\\ occupational\\ safety\\ and\\ health\\ administration\\.\\ http\\:\\/\\/www\\.osha\\.gov\\/sl\\ tc\\/asbestos\\/hazards\\.html\\.\\ accessed\\ oct\\.\\ 7\\,\\ 2015\\.\ \(0\)\
\-\ 10\\.\\	presentation\\,\\ initial\\ evaluation\\,\\ and\\ prognosis\\ of\\ malignant\\ pleural\ \(0\)\
\-\ mesothelioma\\.\\ \\"malignant\\ mesothelioma\\ i\\ ct\\.\\ ed\\.\\ uptodate\\ \\.\\.\\ \\.\\ uptodate\\,\\ 5\\ oct\\ 2016\\.\\ web\\.\\ 05\\ june\\ 2017\\.\ \(0\)\
\-\ 11\\.\\	husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mesothelioma\\:\\ 0\\.06415790846417715\ \(0\)\
\-\ asbestos\\:\\ 0\\.034059185749301446\ \(0\)\
\-\ plant\\:\\ 0\\.029971849606666247\ \(0\)\
\-\ pleural\\:\\ 0\\.026020273698083962\ \(0\)\
\-\ malignant\\:\\ 0\\.02421928113397053\ \(0\)\
\-\ he\\:\\ 0\\.02199434817373634\ \(0\)\
\-\ \\,\\:\\ 0\\.019604003822054485\ \(0\)\
\-\ \\;\\:\\ 0\\.018684697310448282\ \(0\)\
\-\ factory\\:\\ 0\\.017797292747459382\ \(0\)\
\-\ md\\:\\ 0\\.01557342647170446\ \(0\)\
\-\ vats\\:\\ 0\\.015020602700582223\ \(0\)\
\-\ pleurectomy\\:\\ 0\\.013707055466506655\ \(0\)\
\-\ pet\\-ct\\:\\ 0\\.013707055466506655\ \(0\)\
\-\ his\\:\\ 0\\.01363222709029667\ \(0\)\
\-\ \\:\\:\\ 0\\.013554956280330854\ \(0\)\
\-\ 2012\\:\\ 0\\.012565089008256512\ \(0\)\
\-\ exposure\\:\\ 0\\.01230462335285833\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.011395684675924795\ \(0\)\
\-\ worked\\:\\ 0\\.010832249898155089\ \(0\)\
\-\ dc\\:\\ 0\\.010436021639340654\ \(0\)\
\-\ pre\\-operative\\:\\ 0\\.010325908854424902\ \(0\)\
\-\ et\\:\\ 0\\.009679146946832883\ \(0\)\
\-\ was\\:\\ 0\\.0095727988775311\ \(0\)\
\-\ there\\:\\ 0\\.009385354660258218\ \(0\)\
\-\ recalls\\:\\ 0\\.009321139597260142\ \(0\)\
\-\ \\?\\:\\ 0\\.009229371311691438\ \(0\)\
\-\ oncol\\:\\ 0\\.009158155691831565\ \(0\)\
\-\ med\\:\\ 0\\.009047039517598434\ \(0\)\
\-\ effusion\\:\\ 0\\.008986643690605353\ \(0\)\
\-\ tomography\\:\\ 0\\.008426242033057451\ \(0\)\
\-\ al\\:\\ 0\\.00835461617406893\ \(0\)\
\-\ that\\:\\ 0\\.008169635028923376\ \(0\)\
\-\ 2015\\:\\ 0\\.007921322837557447\ \(0\)\
\-\ as\\:\\ 0\\.007750695376671431\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.007695807241374771\ \(0\)\
\-\ fdg\\:\\ 0\\.0076901594362707775\ \(0\)\
\-\ 17\\:\\ 0\\.007678151427691836\ \(0\)\
\-\ part\\:\\ 0\\.0076433387260232315\ \(0\)\
\-\ accessed\\:\\ 0\\.007587611504323746\ \(0\)\
\-\ 2013\\:\\ 0\\.007539053404953907\ \(0\)\
\-\ is\\:\\ 0\\.007521417238541071\ \(0\)\
\-\ manufacturing\\:\\ 0\\.007492962401666562\ \(0\)\
\-\ husain\\:\\ 0\\.007492962401666562\ \(0\)\
\-\ colby\\:\\ 0\\.007492962401666562\ \(0\)\
\-\ ordonez\\:\\ 0\\.007492962401666562\ \(0\)\
\-\ 137\\:647\\:\\ 0\\.007492962401666562\ \(0\)\
\-\ states\\:\\ 0\\.007416472100313204\ \(0\)\
\-\ breath\\:\\ 0\\.007368813556848128\ \(0\)\
\-\ chemical\\:\\ 0\\.007278833527412939\ \(0\)\
\-\ pleura\\:\\ 0\\.007129091482246566\ \(0\)\
\-\ metabolically\\:\\ 0\\.007118917098983753\ \(0\)\
\-\ a\\:\\ 0\\.006951472541100945\ \(0\)\
\-\ n\\:\\ 0\\.006870900584303191\ \(0\)\
\-\ dust\\:\\ 0\\.006853527733253328\ \(0\)\
\-\ statement\\:\\ 0\\.006853527733253328\ \(0\)\
\-\ rep\\:\\ 0\\.006853527733253328\ \(0\)\
\-\ lung\\:\\ 0\\.006850071365974389\ \(0\)\
\-\ no\\:\\ 0\\.006747025166957857\ \(0\)\
\-\ fibers\\:\\ 0\\.0066533928580267895\ \(0\)\
\-\ this\\:\\ 0\\.006649934593963097\ \(0\)\
\-\ update\\:\\ 0\\.006647675748646123\ \(0\)\
\-\ same\\:\\ 0\\.006498549076092262\ \(0\)\
\-\ from\\:\\ 0\\.006425642456040745\ \(0\)\
\-\ rind\\:\\ 0\\.0063372770063756315\ \(0\)\
\-\ positron\\:\\ 0\\.0063372770063756315\ \(0\)\
\-\ sept\\:\\ 0\\.0063372770063756315\ \(0\)\
\-\ patient\\:\\ 0\\.006321711667279616\ \(0\)\
\-\ epithelioid\\:\\ 0\\.006214093064840094\ \(0\)\
\-\ minimal\\:\\ 0\\.006207527620665679\ \(0\)\
\-\ pathol\\:\\ 0\\.006105437127887711\ \(0\)\
\-\ may\\:\\ 0\\.006051798239062208\ \(0\)\
\-\ used\\:\\ 0\\.006048310252671516\ \(0\)\
\-\ unilateral\\:\\ 0\\.00586827598541944\ \(0\)\
\-\ oncologist\\:\\ 0\\.005840047762157285\ \(0\)\
\-\ emission\\:\\ 0\\.005840047762157285\ \(0\)\
\-\ uptodate\\:\\ 0\\.005840047762157285\ \(0\)\
\-\ years\\:\\ 0\\.005786999854747422\ \(0\)\
\-\ consensus\\:\\ 0\\.005766207625927086\ \(0\)\
\-\ interest\\:\\ 0\\.005766207625927086\ \(0\)\
\-\ chest\\:\\ 0\\.005658844096100143\ \(0\)\
\-\ then\\:\\ 0\\.005610639997088726\ \(0\)\
\-\ clearance\\:\\ 0\\.00551873162353347\ \(0\)\
\-\ guidelines\\:\\ 0\\.00551873162353347\ \(0\)\
\-\ international\\:\\ 0\\.00551873162353347\ \(0\)\
\-\ t\\:\\ 0\\.0054737629422576\ \(0\)\
\-\ sternotomy\\:\\ 0\\.005466002459474478\ \(0\)\
\-\ transfusions\\:\\ 0\\.005466002459474478\ \(0\)\
\-\ in\\:\\ 0\\.005442399651257905\ \(0\)\
\-\ diagnosis\\:\\ 0\\.00543049630289784\ \(0\)\
\-\ j\\:\\ 0\\.0053409013372212695\ \(0\)\
\-\ people\\:\\ 0\\.0052398747306617605\ \(0\)\
\-\ oct\\:\\ 0\\.0052398747306617605\ \(0\)\
\-\ which\\:\\ 0\\.005150374589805278\ \(0\)\
\-\ often\\:\\ 0\\.005030394000958768\ \(0\)\
\-\ mediastinal\\:\\ 0\\.0050204787151186476\ \(0\)\
\-\ shortness\\:\\ 0\\.004974855994771457\ \(0\)\
\-\ pa\\:\\ 0\\.004945255639631258\ \(0\)\
\-\ image\\:\\ 0\\.004924703258851662\ \(0\)\
\-\ to\\:\\ 0\\.004924678372266908\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.004826567791061244\ \(0\)\
\-\ at\\:\\ 0\\.0048062123503158196\ \(0\)\
\-\ 77\\:\\ 0\\.004801291984614643\ \(0\)\
\-\ healed\\:\\ 0\\.004752727654831044\ \(0\)\
\-\ uptake\\:\\ 0\\.00469785529247354\ \(0\)\
\-\ products\\:\\ 0\\.004684362366866355\ \(0\)\
\-\ noted\\:\\ 0\\.0046711743276120704\ \(0\)\
\-\ the\\:\\ 0\\.004655072778304743\ \(0\)\
\-\ or\\:\\ 0\\.0046195698752938535\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.0046004400622485266\ \(0\)\
\-\ abuse\\:\\ 0\\.004580600389535461\ \(0\)\
\-\ note\\:\\ 0\\.004563743811118713\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.004542156942671468\ \(0\)\
\-\ active\\:\\ 0\\.004514610939637749\ \(0\)\
\-\ outpatient\\:\\ 0\\.004487338289100618\ \(0\)\
\-\ http\\:\\ 0\\.004477567248127688\ \(0\)\
\-\ following\\:\\ 0\\.004474682208304701\ \(0\)\
\-\ work\\-up\\:\\ 0\\.004452522488378435\ \(0\)\
\-\ include\\:\\ 0\\.0044227924133400124\ \(0\)\
\-\ for\\:\\ 0\\.00437195845588344\ \(0\)\
\-\ an\\:\\ 0\\.004360386953080184\ \(0\)\
\-\ iv\\:\\ 0\\.004315163658848376\ \(0\)\
\-\ case\\:\\ 0\\.0043115877141772846\ \(0\)\
\-\ are\\:\\ 0\\.0042984275739099695\ \(0\)\
\-\ axillary\\:\\ 0\\.004281486304493414\ \(0\)\
\-\ did\\:\\ 0\\.004269490739381352\ \(0\)\
\-\ be\\:\\ 0\\.004254749567992391\ \(0\)\
\-\ computed\\:\\ 0\\.004161857316201409\ \(0\)\
\-\ fact\\:\\ 0\\.00414947445611641\ \(0\)\
\-\ pet\\:\\ 0\\.0041372556122510765\ \(0\)\
\-\ equal\\:\\ 0\\.004125196496414035\ \(0\)\
\-\ group\\:\\ 0\\.004101541117619443\ \(0\)\
\-\ nathan\\:\\ 0\\.004066198535039898\ \(0\)\
\-\ kronenwetter\\:\\ 0\\.004066198535039898\ \(0\)\
\-\ given\\:\\ 0\\.004053617701821507\ \(0\)\
\-\ minor\\:\\ 0\\.004044927698453122\ \(0\)\
\-\ thickening\\:\\ 0\\.004008244330756482\ \(0\)\
\-\ \\(\\:\\ 0\\.003998312137881146\ \(0\)\
\-\ smoking\\:\\ 0\\.003981281138040806\ \(0\)\
\-\ followed\\:\\ 0\\.003964311630136676\ \(0\)\
\-\ hilar\\:\\ 0\\.0039610053938352935\ \(0\)\
\-\ \\)\\:\\ 0\\.003949470620553349\ \(0\)\
\-\ develop\\:\\ 0\\.003931403627643872\ \(0\)\
\-\ overall\\:\\ 0\\.003921743756917585\ \(0\)\
\-\ white\\:\\ 0\\.003921730921649471\ \(0\)\
\-\ initial\\:\\ 0\\.003918240973172474\ \(0\)\
\-\ disease\\:\\ 0\\.003865509800412465\ \(0\)\
\-\ lab\\:\\ 0\\.0038568168226354818\ \(0\)\
\-\ surgery\\:\\ 0\\.0038284115578602856\ \(0\)\
\-\ represents\\:\\ 0\\.003787812013518602\ \(0\)\
\-\ home\\:\\ 0\\.003747166266476138\ \(0\)\
\-\ 170\\.2cm\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 34\\.1\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 129\\/64\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ wheezez\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ coolness\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ muslce\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ supervision\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ effusion\\/thickening\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ post\\-sternotomy\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ basolateral\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ mediport\\-type\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ pleural\\-parenchymal\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ quadruple\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ almethicone\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 125mg\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ albuterol\\-ipratropium\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ senna\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ alprazolam\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ isosorbide\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ mononitrate\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ fluoxetine\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ ferrous\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ tape\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ histroy\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 1970\\.\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ adject\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ stacks\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ fifties\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ benches\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ venting\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ asbestos\\-using\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ asbestos\\-containing\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ sucked\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 1960s\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ plants\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ downwind\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ factories\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ coworker\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ propsed\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ plueral\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ exersion\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ insulation\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ flooring\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 7\\-\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ investigating\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ socola\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ loaiza\\-bonilla\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ bustinza\\-linares\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ purpura\\-like\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 2012\\:619348\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ newland\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ leukocytoclastic\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 6\\:261\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ ty\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ kuss\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ ren\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 32\\:1012\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ bech\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ s0rensen\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 3\\:1359\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ tanriverdi\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ meydan\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ barutca\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ anti\\-yo\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ antibody\\-mediated\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ jpn\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ 43\\:563\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ \\/\\/www\\.nccn\\.org\\/professionals\\/physician\\_gls\\/f\\_guidelines\\.asp\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ niederhuber\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ abeloff\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ \\/\\/www\\.clinicalkey\\.com\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ osha\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ sheet\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ \\/\\/www\\.osha\\.gov\\/sl\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ tc\\/asbestos\\/hazards\\.html\\:\\ 0\\.003746481200833281\ \(0\)\
\-\ right\\:\\ 0\\.0037429360618052355\ \(0\)\
\-\ prognosis\\:\\ 0\\.0037392476837350016\ \(0\)\
\-\ approximately\\:\\ 0\\.0036584195016913044\ \(0\)\
\-\ clinical\\:\\ 0\\.0036383438192795258\ \(0\)\
\-\ and\\:\\ 0\\.003570289320334591\ \(0\)\
\-\ well\\:\\ 0\\.0035665700239274002\ \(0\)\
\-\ 98\\.7\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ unlabored\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ 18f\\-fdg\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ tamsulosin\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ sober\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ opthalmologic\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ settle\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ sf\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ jy\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ yong\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ fort\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ washington\\:\\ 0\\.0035594585494918766\ \(0\)\
\-\ arch\\:\\ 0\\.0035476984542347763\ \(0\)\
\-\ report\\:\\ 0\\.003528676971575426\ \(0\)\
\-\ represent\\:\\ 0\\.0034621064492062095\ \(0\)\
\-\ 5\\:\\ 0\\.0034596315808729195\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0034546360381273937\ \(0\)\
\-\ pathologic\\:\\ 0\\.003450502406579955\ \(0\)\
\-\ under\\:\\ 0\\.0034447546669575967\ \(0\)\
\-\ managing\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ low\\-dose\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ cholecystecomy\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ ranitidine\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ nitroglycerin\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ apartment\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ plastics\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ building\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ retirement\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ mile\\:\\ 0\\.003426763866626664\ \(0\)\
\-\ 2\\:\\ 0\\.0033950267463294208\ \(0\)\
\-\ when\\:\\ 0\\.003386528465335801\ \(0\)\
\-\ findings\\:\\ 0\\.0033557877044095197\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0033521539425040714\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0033316528938096886\ \(0\)\
\-\ ed\\:\\ 0\\.0033316528938096886\ \(0\)\
\-\ cxr\\:\\ 0\\.0033265980360932448\ \(0\)\
\-\ limited\\:\\ 0\\.0033265980360932448\ \(0\)\
\-\ mid\\-thigh\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ oxycodone\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ lipitor\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ naturally\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ brakes\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ shingles\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ clothing\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ fluorodeoxyglucose\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ biological\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ wong\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ thorac\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ network\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ 05\\:\\ 0\\.0033238378743230615\ \(0\)\
\-\ distress\\:\\ 0\\.0033215707254220595\ \(0\)\
\-\ 40\\:\\ 0\\.0033165706631809715\ \(0\)\
\-\ non\\:\\ 0\\.003258592892277223\ \(0\)\
\-\ 9\\:\\ 0\\.003258592892277223\ \(0\)\
\-\ 5\\+\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ encompassing\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ erect\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ atenolol\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ sulfate\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ vent\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ stating\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ talking\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ 2\\-6\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ mineral\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ targeted\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ 2014\\.\\:\\ 0\\.0032397412152852596\ \(0\)\
\-\ 2l\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ 10mg\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ allopurinol\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ remembers\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ coating\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ park\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ 600\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ inhaled\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ plural\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ integrated\\:\\ 0\\.0031686385031878157\ \(0\)\
\-\ currently\\:\\ 0\\.003123775641155034\ \(0\)\
\-\ rheumatic\\:\\ 0\\.003107046532420047\ \(0\)\
\-\ withdrawal\\:\\ 0\\.003107046532420047\ \(0\)\
\-\ occupies\\:\\ 0\\.003107046532420047\ \(0\)\
\-\ lived\\:\\ 0\\.003107046532420047\ \(0\)\
\-\ jb\\:\\ 0\\.003107046532420047\ \(0\)\
\-\ 2016\\.\\:\\ 0\\.003107046532420047\ \(0\)\
\-\ moderate\\:\\ 0\\.003099813015321768\ \(0\)\
\-\ pressure\\:\\ 0\\.003095879068101789\ \(0\)\
\-\ extremities\\:\\ 0\\.0030919618255912254\ \(0\)\
\-\ base\\:\\ 0\\.003088061146523401\ \(0\)\
\-\ failure\\:\\ 0\\.003088061146523401\ \(0\)\
\-\ who\\:\\ 0\\.0030829821159709895\ \(0\)\
\-\ these\\:\\ 0\\.0030772758652553136\ \(0\)\
\-\ patients\\:\\ 0\\.0030602969548422865\ \(0\)\
\-\ air\\-space\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ mediport\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ cataract\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ house\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ dullness\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ respiration\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ plays\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ pursued\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ cured\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ sc\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ je\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ livingstone\\:\\ 0\\.0030527185639438554\ \(0\)\
\-\ process\\:\\ 0\\.0030351157609176333\ \(0\)\
\-\ images\\:\\ 0\\.003024472125367812\ \(0\)\
\-\ 7\\:\\ 0\\.0030205303310037565\ \(0\)\
\-\ on\\:\\ 0\\.0030050826159081427\ \(0\)\
\-\ vacuum\\:\\ 0\\.003004120540116445\ \(0\)\
\-\ predisposition\\:\\ 0\\.003004120540116445\ \(0\)\
\-\ churchill\\:\\ 0\\.003004120540116445\ \(0\)\
\-\ its\\:\\ 0\\.002974660003187861\ \(0\)\
\-\ has\\:\\ 0\\.0029607010525724686\ \(0\)\
\-\ postsurgical\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ address\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ avulsed\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ plavix\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ adhesive\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ daughter\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ son\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ swallowed\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ someone\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ safety\\:\\ 0\\.0029601582800590992\ \(0\)\
\-\ think\\:\\ 0\\.0029200238810786427\ \(0\)\
\-\ pshx\\:\\ 0\\.0029200238810786427\ \(0\)\
\-\ hemicolectomy\\:\\ 0\\.0029200238810786427\ \(0\)\
\-\ quit\\:\\ 0\\.0029200238810786427\ \(0\)\
\-\ carry\\:\\ 0\\.0029200238810786427\ \(0\)\
\-\ john\\:\\ 0\\.0029200238810786427\ \(0\)\
\-\ acute\\:\\ 0\\.0029195747173982865\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.002906090919232219\ \(0\)\
\-\ diagnosed\\:\\ 0\\.002898704019183584\ \(0\)\
\-\ thoracotomy\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ cad\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ grown\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ occuring\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ encasement\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ bj\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ elsevier\\:\\ 0\\.002883103812963543\ \(0\)\
\-\ risk\\:\\ 0\\.002855356685755615\ \(0\)\
\-\ bronchitis\\:\\ 0\\.0028489211689811987\ \(0\)\
\-\ 2003\\.\\:\\ 0\\.0028489211689811987\ \(0\)\
\-\ understood\\:\\ 0\\.0028489211689811987\ \(0\)\
\-\ trials\\:\\ 0\\.0028489211689811987\ \(0\)\
\-\ eds\\:\\ 0\\.0028489211689811987\ \(0\)\
\-\ of\\:\\ 0\\.002848109521353038\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0028255957427498757\ \(0\)\
\-\ asbestosis\\:\\ 0\\.0028170978887750403\ \(0\)\
\-\ broken\\:\\ 0\\.0028170978887750403\ \(0\)\
\-\ fail\\:\\ 0\\.0028170978887750403\ \(0\)\
\-\ al\\.\\:\\ 0\\.0028170978887750403\ \(0\)\
\-\ 2017\\:\\ 0\\.0028170978887750403\ \(0\)\
\-\ 1\\:\\ 0\\.0028136434980992253\ \(0\)\
\-\ would\\:\\ 0\\.002805319998544363\ \(0\)\
\-\ obtained\\:\\ 0\\.0028024595025312195\ \(0\)\
\-\ weighs\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ wires\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ former\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ discovery\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ variation\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ thrombotic\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ national\\:\\ 0\\.0027873291982134303\ \(0\)\
\-\ 3\\:\\ 0\\.0027688775738559128\ \(0\)\
\-\ yielded\\:\\ 0\\.002759365811766735\ \(0\)\
\-\ comprehensive\\:\\ 0\\.002759365811766735\ \(0\)\
\-\ ct\\:\\ 0\\.002756696617601575\ \(0\)\
\-\ tall\\:\\ 0\\.002733001229737239\ \(0\)\
\-\ issue\\:\\ 0\\.002733001229737239\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.002733001229737239\ \(0\)\
\-\ presentation\\:\\ 0\\.002715314238460408\ \(0\)\
\-\ vertex\\:\\ 0\\.0027080624745387722\ \(0\)\
\-\ plastic\\:\\ 0\\.0027080624745387722\ \(0\)\
\-\ underwent\\:\\ 0\\.002704977892507582\ \(0\)\
\-\ lives\\:\\ 0\\.002684403205909828\ \(0\)\
\-\ conjunction\\:\\ 0\\.002684403205909828\ \(0\)\
\-\ can\\:\\ 0\\.0026820420006490814\ \(0\)\
\-\ air\\:\\ 0\\.00266721644515864\ \(0\)\
\-\ resistant\\:\\ 0\\.0026618985176397945\ \(0\)\
\-\ irritation\\:\\ 0\\.0026618985176397945\ \(0\)\
\-\ bmi\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ scars\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ excess\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ hoarseness\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ curative\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ therapies\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ gene\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ occupational\\:\\ 0\\.0026404409458524827\ \(0\)\
\-\ living\\:\\ 0\\.0026199373653308803\ \(0\)\
\-\ \\.\\.\\:\\ 0\\.0026199373653308803\ \(0\)\
\-\ \\'s\\:\\ 0\\.0026070755789211874\ \(0\)\
\-\ illicit\\:\\ 0\\.0026003065468720257\ \(0\)\
\-\ cancer\\:\\ 0\\.002591480871185208\ \(0\)\
\-\ seated\\:\\ 0\\.0025814772136062256\ \(0\)\
\-\ pre\\-op\\:\\ 0\\.0025814772136062256\ \(0\)\
\-\ aspirin\\:\\ 0\\.0025814772136062256\ \(0\)\
\-\ etoh\\:\\ 0\\.0025814772136062256\ \(0\)\
\-\ phenomenon\\:\\ 0\\.0025814772136062256\ \(0\)\
\-\ june\\:\\ 0\\.0025814772136062256\ \(0\)\
\-\ ppd\\:\\ 0\\.002563386478756926\ \(0\)\
\-\ specificity\\:\\ 0\\.002563386478756926\ \(0\)\
\-\ have\\:\\ 0\\.002560569296630662\ \(0\)\
\-\ kg\\:\\ 0\\.0025459785783958342\ \(0\)\
\-\ mascaro\\:\\ 0\\.0025459785783958342\ \(0\)\
\-\ terms\\:\\ 0\\.0025459785783958342\ \(0\)\
\-\ decades\\:\\ 0\\.002529203834774582\ \(0\)\
\-\ gradual\\:\\ 0\\.002529203834774582\ \(0\)\
\-\ orientation\\:\\ 0\\.0025130178016513024\ \(0\)\
\-\ clips\\:\\ 0\\.0025130178016513024\ \(0\)\
\-\ working\\:\\ 0\\.0025130178016513024\ \(0\)\
\-\ oncology\\:\\ 0\\.0025130178016513024\ \(0\)\
\-\ 2\\.\\:\\ 0\\.002506867289483633\ \(0\)\
\-\ incision\\:\\ 0\\.0024973805545684237\ \(0\)\
\-\ pack\\:\\ 0\\.0024973805545684237\ \(0\)\
\-\ found\\:\\ 0\\.002484340972741801\ \(0\)\
\-\ lieberman\\:\\ 0\\.002482256097546749\ \(0\)\
\-\ ongoing\\:\\ 0\\.002482256097546749\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.0024676118640068133\ \(0\)\
\-\ xray\\:\\ 0\\.0024676118640068133\ \(0\)\
\-\ heat\\:\\ 0\\.0024676118640068133\ \(0\)\
\-\ infiltrates\\:\\ 0\\.002453418294511078\ \(0\)\
\-\ web\\:\\ 0\\.002453418294511078\ \(0\)\
\-\ 11\\.\\:\\ 0\\.002453418294511078\ \(0\)\
\-\ after\\:\\ 0\\.0024464961290717744\ \(0\)\
\-\ clubbing\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ congestive\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ bypass\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ exact\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ surgeons\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ 2010\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ 10\\.\\:\\ 0\\.002439648477560118\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.00242627784247098\ \(0\)\
\-\ jeffrey\\:\\ 0\\.00242627784247098\ \(0\)\
\-\ medical\\:\\ 0\\.0024255625461863505\ \(0\)\
\-\ normocephalic\\:\\ 0\\.002413283895530622\ \(0\)\
\-\ myocardial\\:\\ 0\\.002413283895530622\ \(0\)\
\-\ during\\:\\ 0\\.0024123701567562803\ \(0\)\
\-\ rash\\:\\ 0\\.0024006459923073217\ \(0\)\
\-\ remove\\:\\ 0\\.0024006459923073217\ \(0\)\
\-\ some\\:\\ 0\\.0023938452526446117\ \(0\)\
\-\ roof\\:\\ 0\\.0023883451403321552\ \(0\)\
\-\ production\\:\\ 0\\.0023883451403321552\ \(0\)\
\-\ rhonchi\\:\\ 0\\.002376363827415522\ \(0\)\
\-\ gerd\\:\\ 0\\.002376363827415522\ \(0\)\
\-\ percussion\\:\\ 0\\.002376363827415522\ \(0\)\
\-\ projecting\\:\\ 0\\.002364685871703211\ \(0\)\
\-\ copd\\:\\ 0\\.002364685871703211\ \(0\)\
\-\ fingers\\:\\ 0\\.002364685871703211\ \(0\)\
\-\ 0\\:\\ 0\\.002364685871703211\ \(0\)\
\-\ gallops\\:\\ 0\\.002353296290250088\ \(0\)\
\-\ doing\\:\\ 0\\.0023421811834331775\ \(0\)\
\-\ jennifer\\:\\ 0\\.0023421811834331775\ \(0\)\
\-\ sperrazza\\:\\ 0\\.0023421811834331775\ \(0\)\
\-\ e\\:\\ 0\\.0023421811834331775\ \(0\)\
\-\ primary\\:\\ 0\\.0023352253347746275\ \(0\)\
\-\ pmhx\\:\\ 0\\.002331327632967221\ \(0\)\
\-\ role\\:\\ 0\\.002331327632967221\ \(0\)\
\-\ never\\:\\ 0\\.0023207236116458657\ \(0\)\
\-\ clin\\:\\ 0\\.0023207236116458657\ \(0\)\
\-\ cyanosis\\:\\ 0\\.0023103579032270195\ \(0\)\
\-\ allergies\\:\\ 0\\.0023103579032270195\ \(0\)\
\-\ died\\:\\ 0\\.0023103579032270195\ \(0\)\
\-\ 9\\.\\:\\ 0\\.0023103579032270195\ \(0\)\
\-\ scarring\\:\\ 0\\.0023002200311242633\ \(0\)\
\-\ social\\:\\ 0\\.0023002200311242633\ \(0\)\
\-\ lutnick\\:\\ 0\\.0023002200311242633\ \(0\)\
\-\ ultimately\\:\\ 0\\.0023002200311242633\ \(0\)\
\-\ strong\\:\\ 0\\.0022903001947677305\ \(0\)\
\-\ median\\:\\ 0\\.0022805892126654096\ \(0\)\
\-\ reconstruction\\:\\ 0\\.0022805892126654096\ \(0\)\
\-\ post\\-operative\\:\\ 0\\.0022805892126654096\ \(0\)\
\-\ spectrum\\:\\ 0\\.0022805892126654096\ \(0\)\
\-\ 2008\\:\\ 0\\.0022805892126654096\ \(0\)\
\-\ croce\\:\\ 0\\.002271078471335734\ \(0\)\
\-\ gary\\:\\ 0\\.002271078471335734\ \(0\)\
\-\ staging\\:\\ 0\\.002271078471335734\ \(0\)\
\-\ rubs\\:\\ 0\\.0022617598793996086\ \(0\)\
\-\ jugular\\:\\ 0\\.0022617598793996086\ \(0\)\
\-\ iqbal\\:\\ 0\\.0022617598793996086\ \(0\)\
\-\ unfortunately\\:\\ 0\\.0022617598793996086\ \(0\)\
\-\ s\\:\\ 0\\.002260855781471021\ \(0\)\
\-\ changes\\:\\ 0\\.002259269350770351\ \(0\)\
\-\ syndrome\\:\\ 0\\.0022545263623013297\ \(0\)\
\-\ correction\\:\\ 0\\.002252625826218714\ \(0\)\
\-\ bases\\:\\ 0\\.002252625826218714\ \(0\)\
\-\ robert\\:\\ 0\\.002252625826218714\ \(0\)\
\-\ scott\\:\\ 0\\.002252625826218714\ \(0\)\
\-\ tirone\\:\\ 0\\.002252625826218714\ \(0\)\
\-\ abnormal\\:\\ 0\\.0022482400740912465\ \(0\)\
\-\ frank\\:\\ 0\\.002243669144550309\ \(0\)\
\-\ affects\\:\\ 0\\.002243669144550309\ \(0\)\
\-\ ages\\:\\ 0\\.0022348830767593988\ \(0\)\
\-\ rectal\\:\\ 0\\.0022348830767593988\ \(0\)\
\-\ transformation\\:\\ 0\\.0022348830767593988\ \(0\)\
\-\ \\.\\:\\ 0\\.0022269081684682165\ \(0\)\
\-\ time\\:\\ 0\\.002226569397822244\ \(0\)\
\-\ deformities\\:\\ 0\\.0022262612441892177\ \(0\)\
\-\ hemithorax\\:\\ 0\\.0022262612441892177\ \(0\)\
\-\ charles\\:\\ 0\\.0022262612441892177\ \(0\)\
\-\ vaseem\\:\\ 0\\.0022262612441892177\ \(0\)\
\-\ progress\\:\\ 0\\.0022262612441892177\ \(0\)\
\-\ sensitivity\\:\\ 0\\.0022262612441892177\ \(0\)\
\-\ childhood\\:\\ 0\\.0022177976193422633\ \(0\)\
\-\ floor\\:\\ 0\\.0022177976193422633\ \(0\)\
\-\ tone\\:\\ 0\\.002209486500567965\ \(0\)\
\-\ gout\\:\\ 0\\.002209486500567965\ \(0\)\
\-\ philadelphia\\:\\ 0\\.002209486500567965\ \(0\)\
\-\ 8\\.\\:\\ 0\\.002201322488990751\ \(0\)\
\-\ however\\:\\ 0\\.0021949889811781094\ \(0\)\
\-\ smith\\:\\ 0\\.002193300467444686\ \(0\)\
\-\ health\\:\\ 0\\.0021854155812088463\ \(0\)\
\-\ s2\\:\\ 0\\.002170039003594643\ \(0\)\
\-\ rales\\:\\ 0\\.002170039003594643\ \(0\)\
\-\ htn\\:\\ 0\\.002170039003594643\ \(0\)\
\-\ directly\\:\\ 0\\.0021625387633401323\ \(0\)\
\-\ pupils\\:\\ 0\\.0021551585320917738\ \(0\)\
\-\ morning\\:\\ 0\\.0021551585320917738\ \(0\)\
\-\ facility\\:\\ 0\\.0021551585320917738\ \(0\)\
\-\ blood\\:\\ 0\\.0021516707310971395\ \(0\)\
\-\ stated\\:\\ 0\\.0021478945298001964\ \(0\)\
\-\ randall\\:\\ 0\\.002140743152246707\ \(0\)\
\-\ loftus\\:\\ 0\\.002140743152246707\ \(0\)\
\-\ male\\:\\ 0\\.002138199545047241\ \(0\)\
\-\ excluded\\:\\ 0\\.0021337009603044615\ \(0\)\
\-\ murmurs\\:\\ 0\\.0021199311433535016\ \(0\)\
\-\ protocol\\:\\ 0\\.0021199311433535016\ \(0\)\
\-\ assessment\\:\\ 0\\.0021199311433535016\ \(0\)\
\-\ literature\\:\\ 0\\.0021199311433535016\ \(0\)\
\-\ up\\:\\ 0\\.002119785194699468\ \(0\)\
\-\ fissure\\:\\ 0\\.002113197379782859\ \(0\)\
\-\ survival\\:\\ 0\\.002113197379782859\ \(0\)\
\-\ therapy\\:\\ 0\\.002107602210554071\ \(0\)\
\-\ ms\\:\\ 0\\.002106560508264363\ \(0\)\
\-\ 41\\:\\ 0\\.00210001777994704\ \(0\)\
\-\ li\\:\\ 0\\.00210001777994704\ \(0\)\
\-\ 7\\.\\:\\ 0\\.00210001777994704\ \(0\)\
\-\ krishnan\\:\\ 0\\.0020872043278681307\ \(0\)\
\-\ kartha\\:\\ 0\\.0020872043278681307\ \(0\)\
\-\ mild\\:\\ 0\\.002075879570047174\ \(0\)\
\-\ joanna\\:\\ 0\\.0020686278061255382\ \(0\)\
\-\ garvey\\:\\ 0\\.0020686278061255382\ \(0\)\
\-\ serghany\\:\\ 0\\.0020686278061255382\ \(0\)\
\-\ thick\\:\\ 0\\.0020686278061255382\ \(0\)\
\-\ evidence\\:\\ 0\\.002066828951445459\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.0020625982482070176\ \(0\)\
\-\ geoffrey\\:\\ 0\\.0020625982482070176\ \(0\)\
\-\ gerow\\:\\ 0\\.0020625982482070176\ \(0\)\
\-\ f\\:\\ 0\\.0020566464932089052\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0020507705588097215\ \(0\)\
\-\ rhythm\\:\\ 0\\.002044968537496594\ \(0\)\
\-\ suspicion\\:\\ 0\\.002044968537496594\ \(0\)\
\-\ joseph\\:\\ 0\\.002039238592847813\ \(0\)\
\-\ s1\\:\\ 0\\.002033578956043471\ \(0\)\
\-\ nonspecific\\:\\ 0\\.002027987922587592\ \(0\)\
\-\ mechanism\\:\\ 0\\.002027987922587592\ \(0\)\
\-\ 5th\\:\\ 0\\.002027987922587592\ \(0\)\
\-\ drug\\:\\ 0\\.002022463849226561\ \(0\)\
\-\ significantly\\:\\ 0\\.0020170051510498993\ \(0\)\
\-\ feet\\:\\ 0\\.0020170051510498993\ \(0\)\
\-\ once\\:\\ 0\\.0020170051510498993\ \(0\)\
\-\ vasculitis\\:\\ 0\\.0020170051510498993\ \(0\)\
\-\ factor\\:\\ 0\\.0020116102987606044\ \(0\)\
\-\ confirm\\:\\ 0\\.0020062778161032816\ \(0\)\
\-\ degeneration\\:\\ 0\\.0020010062774392487\ \(0\)\
\-\ began\\:\\ 0\\.0019957943054586527\ \(0\)\
\-\ anatomic\\:\\ 0\\.001990640569020403\ \(0\)\
\-\ alcohol\\:\\ 0\\.0019855437811114613\ \(0\)\
\-\ older\\:\\ 0\\.0019855437811114613\ \(0\)\
\-\ diseases\\:\\ 0\\.0019855437811114613\ \(0\)\
\-\ movement\\:\\ 0\\.0019705828605611135\ \(0\)\
\-\ by\\:\\ 0\\.0019689173015381106\ \(0\)\
\-\ symptoms\\:\\ 0\\.0019646286687252205\ \(0\)\
\-\ progression\\:\\ 0\\.0019608718784587926\ \(0\)\
\-\ extent\\:\\ 0\\.0019560919951398135\ \(0\)\
\-\ residual\\:\\ 0\\.0019560919951398135\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.0019560919951398135\ \(0\)\
\-\ 34\\:\\ 0\\.0019560919951398135\ \(0\)\
\-\ arise\\:\\ 0\\.001951361137129117\ \(0\)\
\-\ definitive\\:\\ 0\\.0019466783089630575\ \(0\)\
\-\ hearing\\:\\ 0\\.0019420425451929918\ \(0\)\
\-\ discovered\\:\\ 0\\.0019420425451929918\ \(0\)\
\-\ expansion\\:\\ 0\\.0019420425451929918\ \(0\)\
\-\ physical\\:\\ 0\\.0019340454516432086\ \(0\)\
\-\ consistent\\:\\ 0\\.001932931982316608\ \(0\)\
\-\ interstitial\\:\\ 0\\.0019284084113177409\ \(0\)\
\-\ poorly\\:\\ 0\\.0019239518103436927\ \(0\)\
\-\ dysphagia\\:\\ 0\\.001919537856922959\ \(0\)\
\-\ night\\:\\ 0\\.001915165742552782\ \(0\)\
\-\ asymmetric\\:\\ 0\\.001915165742552782\ \(0\)\
\-\ 6\\.\\:\\ 0\\.001915165742552782\ \(0\)\
\-\ heent\\:\\ 0\\.0019065439099826007\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0019001379169577887\ \(0\)\
\-\ suspicious\\:\\ 0\\.0018980802851356466\ \(0\)\
\-\ mediastinum\\:\\ 0\\.0018980802851356466\ \(0\)\
\-\ catheter\\:\\ 0\\.001893906006759301\ \(0\)\
\-\ gallbladder\\:\\ 0\\.001893906006759301\ \(0\)\
\-\ observed\\:\\ 0\\.0018897691663613482\ \(0\)\
\-\ leading\\:\\ 0\\.0018856690983644637\ \(0\)\
\-\ improved\\:\\ 0\\.0018775767046140444\ \(0\)\
\-\ become\\:\\ 0\\.0018775767046140444\ \(0\)\
\-\ relative\\:\\ 0\\.0018775767046140444\ \(0\)\
\-\ c\\:\\ 0\\.001873583133238069\ \(0\)\
\-\ shift\\:\\ 0\\.0018696238418675008\ \(0\)\
\-\ reactive\\:\\ 0\\.0018656982470022293\ \(0\)\
\-\ visible\\:\\ 0\\.0018656982470022293\ \(0\)\
\-\ dyspnea\\:\\ 0\\.0018656982470022293\ \(0\)\
\-\ volume\\:\\ 0\\.0018618057799146535\ \(0\)\
\-\ physician\\:\\ 0\\.0018579458861551902\ \(0\)\
\-\ short\\:\\ 0\\.0018579458861551902\ \(0\)\
\-\ ordered\\:\\ 0\\.001854118025078301\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.0018503216693880266\ \(0\)\
\-\ imaging\\:\\ 0\\.0018469315723760172\ \(0\)\
\-\ work\\:\\ 0\\.0018465563047020666\ \(0\)\
\-\ light\\:\\ 0\\.0018391165528893899\ \(0\)\
\-\ tumor\\:\\ 0\\.001837852676762741\ \(0\)\
\-\ gait\\:\\ 0\\.001835441197885157\ \(0\)\
\-\ regular\\:\\ 0\\.0018174912826408424\ \(0\)\
\-\ other\\:\\ 0\\.0018170097312753216\ \(0\)\
\-\ regions\\:\\ 0\\.0018036179176789985\ \(0\)\
\-\ decrease\\:\\ 0\\.0018036179176789985\ \(0\)\
\-\ l\\:\\ 0\\.0017968346393627183\ \(0\)\
\-\ were\\:\\ 0\\.0017899320449169015\ \(0\)\
\-\ incidentally\\:\\ 0\\.0017868431740577463\ \(0\)\
\-\ overlying\\:\\ 0\\.0017835602092197093\ \(0\)\
\-\ present\\:\\ 0\\.0017804508800107757\ \(0\)\
\-\ generally\\:\\ 0\\.0017738492271173881\ \(0\)\
\-\ poor\\:\\ 0\\.0017738492271173881\ \(0\)\
\-\ few\\:\\ 0\\.0017738492271173881\ \(0\)\
\-\ it\\:\\ 0\\.0017720003547352552\ \(0\)\
\-\ gi\\:\\ 0\\.0017706571409344665\ \(0\)\
\-\ factors\\:\\ 0\\.0017706571409344665\ \(0\)\
\-\ year\\:\\ 0\\.0017640318621271489\ \(0\)\
\-\ medications\\:\\ 0\\.001758105220489409\ \(0\)\
\-\ even\\:\\ 0\\.0017550198938515878\ \(0\)\
\-\ appearing\\:\\ 0\\.001751955067874342\ \(0\)\
\-\ strength\\:\\ 0\\.0017489104719189215\ \(0\)\
\-\ necessary\\:\\ 0\\.001745885840670693\ \(0\)\
\-\ resulting\\:\\ 0\\.0017310532246031048\ \(0\)\
\-\ until\\:\\ 0\\.0017310532246031048\ \(0\)\
\-\ their\\:\\ 0\\.0017252512032899774\ \(0\)\
\-\ large\\:\\ 0\\.0017237476308404793\ \(0\)\
\-\ point\\:\\ 0\\.0017223773334787984\ \(0\)\
\-\ 60\\:\\ 0\\.0017195212586411965\ \(0\)\
\-\ development\\:\\ 0\\.0017166827597600257\ \(0\)\
\-\ bleeding\\:\\ 0\\.0017110576337942423\ \(0\)\
\-\ not\\:\\ 0\\.0017086974239971429\ \(0\)\
\-\ review\\:\\ 0\\.0017082705883809755\ \(0\)\
\-\ children\\:\\ 0\\.0017027465150199442\ \(0\)\
\-\ had\\:\\ 0\\.0017009684679342326\ \(0\)\
\-\ 5\\.\\:\\ 0\\.0017000090908871886\ \(0\)\
\-\ cerebellar\\:\\ 0\\.0017000090908871886\ \(0\)\
\-\ another\\:\\ 0\\.0016945825034427296\ \(0\)\
\-\ stage\\:\\ 0\\.0016812889432326322\ \(0\)\
\-\ but\\:\\ 0\\.001681276107964518\ \(0\)\
\-\ skull\\:\\ 0\\.0016786755956608253\ \(0\)\
\-\ rupture\\:\\ 0\\.0016734929050395493\ \(0\)\
\-\ features\\:\\ 0\\.0016632990180466224\ \(0\)\
\-\ denies\\:\\ 0\\.0016632990180466224\ \(0\)\
\-\ recurrent\\:\\ 0\\.0016632990180466224\ \(0\)\
\-\ general\\:\\ 0\\.0016607853627110297\ \(0\)\
\-\ oral\\:\\ 0\\.0016607853627110297\ \(0\)\
\-\ s\\/p\\:\\ 0\\.001653325556785937\ \(0\)\
\-\ outside\\:\\ 0\\.001653325556785937\ \(0\)\
\-\ arm\\:\\ 0\\.0016508655263544967\ \(0\)\
\-\ traumatic\\:\\ 0\\.0016508655263544967\ \(0\)\
\-\ procedure\\:\\ 0\\.0016508655263544967\ \(0\)\
\-\ just\\:\\ 0\\.001645984479615319\ \(0\)\
\-\ position\\:\\ 0\\.0016411545442521756\ \(0\)\
\-\ absence\\:\\ 0\\.0016387584110062788\ \(0\)\
\-\ references\\:\\ 0\\.0016387584110062788\ \(0\)\
\-\ respiratory\\:\\ 0\\.0016363746609331965\ \(0\)\
\-\ administration\\:\\ 0\\.0016363746609331965\ \(0\)\
\-\ history\\:\\ 0\\.001633138197934156\ \(0\)\
\-\ i\\:\\ 0\\.0016292964461386114\ \(0\)\
\-\ films\\:\\ 0\\.0016269609747564405\ \(0\)\
\-\ related\\:\\ 0\\.0016269609747564405\ \(0\)\
\-\ nodule\\:\\ 0\\.0016246372690230655\ \(0\)\
\-\ thin\\:\\ 0\\.0016200246844591433\ \(0\)\
\-\ many\\:\\ 0\\.0016200246844591433\ \(0\)\
\-\ increasing\\:\\ 0\\.0016154577697992207\ \(0\)\
\-\ family\\:\\ 0\\.0016154577697992207\ \(0\)\
\-\ pathology\\:\\ 0\\.0016131911578054804\ \(0\)\
\-\ 12\\:\\ 0\\.0016131911578054804\ \(0\)\
\-\ infarction\\:\\ 0\\.0016109356295332517\ \(0\)\
\-\ initially\\:\\ 0\\.0016042344761370757\ \(0\)\
\-\ placement\\:\\ 0\\.0015998205227163418\ \(0\)\
\-\ treatment\\:\\ 0\\.0015955876011078294\ \(0\)\
\-\ visualized\\:\\ 0\\.0015954484083461648\ \(0\)\
\-\ reports\\:\\ 0\\.0015889669722503853\ \(0\)\
\-\ attenuation\\:\\ 0\\.0015846960656946672\ \(0\)\
\-\ shown\\:\\ 0\\.0015804643423201095\ \(0\)\
\-\ typical\\:\\ 0\\.0015804643423201095\ \(0\)\
\-\ additional\\:\\ 0\\.0015804643423201095\ \(0\)\
\-\ sounds\\:\\ 0\\.0015721156146247138\ \(0\)\
\-\ complications\\:\\ 0\\.001561887820577517\ \(0\)\
\-\ also\\:\\ 0\\.001554077115931874\ \(0\)\
\-\ worsening\\:\\ 0\\.0015518819051664196\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0015518819051664196\ \(0\)\
\-\ colon\\:\\ 0\\.0015479395340508946\ \(0\)\
\-\ rate\\:\\ 0\\.0015363106505884884\ \(0\)\
\-\ change\\:\\ 0\\.0015363106505884884\ \(0\)\
\-\ midline\\:\\ 0\\.0015249677524624174\ \(0\)\
\-\ about\\:\\ 0\\.001519399218682773\ \(0\)\
\-\ skin\\:\\ 0\\.001513897110350082\ \(0\)\
\-\ result\\:\\ 0\\.001512077563167879\ \(0\)\
\-\ cough\\:\\ 0\\.0015102651655018783\ \(0\)\
\-\ pattern\\:\\ 0\\.0015066615955125822\ \(0\)\
\-\ within\\:\\ 0\\.0015038112623487838\ \(0\)\
\-\ cardiac\\:\\ 0\\.0015013084838334733\ \(0\)\
\-\ lungs\\:\\ 0\\.0014925224160425626\ \(0\)\
\-\ referred\\:\\ 0\\.0014873300015939305\ \(0\)\
\-\ course\\:\\ 0\\.0014873300015939305\ \(0\)\
\-\ tumors\\:\\ 0\\.0014804964749402679\ \(0\)\
\-\ metastasis\\:\\ 0\\.0014754369586254274\ \(0\)\
\-\ appears\\:\\ 0\\.0014671258398511293\ \(0\)\
\-\ sided\\:\\ 0\\.001457346223776128\ \(0\)\
\-\ clear\\:\\ 0\\.001457346223776128\ \(0\)\
\-\ since\\:\\ 0\\.001447769659454897\ \(0\)\
\-\ abnormalities\\:\\ 0\\.001447769659454897\ \(0\)\
\-\ involvement\\:\\ 0\\.001444621151581096\ \(0\)\
\-\ early\\:\\ 0\\.0014414939896874712\ \(0\)\
\-\ reported\\:\\ 0\\.0014368426432545258\ \(0\)\
\-\ vein\\:\\ 0\\.0014261685064640762\ \(0\)\
\-\ including\\:\\ 0\\.001423163579793784\ \(0\)\
\-\ care\\:\\ 0\\.0014216684257697197\ \(0\)\
\-\ they\\:\\ 0\\.0014201781026232962\ \(0\)\
\-\ 20\\:\\ 0\\.0014172118247956715\ \(0\)\
\-\ biopsy\\:\\ 0\\.0013983824915298712\ \(0\)\
\-\ typically\\:\\ 0\\.0013913402995876256\ \(0\)\
\-\ being\\:\\ 0\\.0013735184394836524\ \(0\)\
\-\ heart\\:\\ 0\\.0013695016830760028\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0013668431476900479\ \(0\)\
\-\ side\\:\\ 0\\.001365519604134719\ \(0\)\
\-\ benign\\:\\ 0\\.0013602630844249083\ \(0\)\
\-\ 3\\.\\:\\ 0\\.001348650466854579\ \(0\)\
\-\ now\\:\\ 0\\.00134737803953028\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0013423231438708155\ \(0\)\
\-\ inferior\\:\\ 0\\.0013373230449073169\ \(0\)\
\-\ fever\\:\\ 0\\.00133360822257932\ \(0\)\
\-\ although\\:\\ 0\\.00133114819214788\ \(0\)\
\-\ type\\:\\ 0\\.0013287012123371358\ \(0\)\
\-\ 10\\:\\ 0\\.0013287012123371358\ \(0\)\
\-\ internal\\:\\ 0\\.0013214372100455588\ \(0\)\
\-\ size\\:\\ 0\\.0013214372100455588\ \(0\)\
\-\ cases\\:\\ 0\\.0013131046420577178\ \(0\)\
\-\ out\\:\\ 0\\.0013026078767797583\ \(0\)\
\-\ study\\:\\ 0\\.0012968779321309773\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0012946057373265237\ \(0\)\
\-\ radiation\\:\\ 0\\.0012934738235988636\ \(0\)\
\-\ revealed\\:\\ 0\\.0012649787314880504\ \(0\)\
\-\ medial\\:\\ 0\\.0012607470081134925\ \(0\)\
\-\ superior\\:\\ 0\\.001258645616722413\ \(0\)\
\-\ follow\\:\\ 0\\.0012523982804180968\ \(0\)\
\-\ day\\:\\ 0\\.0012513652349413881\ \(0\)\
\-\ adjacent\\:\\ 0\\.0012462344299512301\ \(0\)\
\-\ any\\:\\ 0\\.0012411600706053014\ \(0\)\
\-\ while\\:\\ 0\\.0012401518634005135\ \(0\)\
\-\ normal\\:\\ 0\\.001235804847416145\ \(0\)\
\-\ will\\:\\ 0\\.001233155451281892\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0012311758147129156\ \(0\)\
\-\ show\\:\\ 0\\.0012099427742120045\ \(0\)\
\-\ age\\:\\ 0\\.0011996818844761561\ \(0\)\
\-\ diffuse\\:\\ 0\\.0011932691053391674\ \(0\)\
\-\ only\\:\\ 0\\.0011851529790059667\ \(0\)\
\-\ renal\\:\\ 0\\.0011842599397869323\ \(0\)\
\-\ treated\\:\\ 0\\.0011798204963486434\ \(0\)\
\-\ 6\\:\\ 0\\.0011771771962061227\ \(0\)\
\-\ negative\\:\\ 0\\.0011771771962061227\ \(0\)\
\-\ decreased\\:\\ 0\\.001171935610112804\ \(0\)\
\-\ abdomen\\:\\ 0\\.0011676126673873138\ \(0\)\
\-\ neck\\:\\ 0\\.0011573999709494846\ \(0\)\
\-\ evaluation\\:\\ 0\\.001144944094016055\ \(0\)\
\-\ loss\\:\\ 0\\.0011441255408064757\ \(0\)\
\-\ wall\\:\\ 0\\.0011416785609957316\ \(0\)\
\-\ appearance\\:\\ 0\\.0011272631811506649\ \(0\)\
\-\ axial\\:\\ 0\\.0011249038173744795\ \(0\)\
\-\ fluid\\:\\ 0\\.0011202209892084193\ \(0\)\
\-\ weeks\\:\\ 0\\.0011186705520761754\ \(0\)\
\-\ edema\\:\\ 0\\.0011148171076712596\ \(0\)\
\-\ all\\:\\ 0\\.0011148171076712596\ \(0\)\
\-\ likely\\:\\ 0\\.0011117573643614652\ \(0\)\
\-\ chronic\\:\\ 0\\.001110235070529059\ \(0\)\
\-\ 4\\:\\ 0\\.0010982342736065706\ \(0\)\
\-\ months\\:\\ 0\\.0010765411875876694\ \(0\)\
\-\ presented\\:\\ 0\\.0010744269534236205\ \(0\)\
\-\ been\\:\\ 0\\.0010723223659889257\ \(0\)\
\-\ distal\\:\\ 0\\.0010716229653810086\ \(0\)\
\-\ if\\:\\ 0\\.0010695311041423595\ \(0\)\
\-\ due\\:\\ 0\\.0010517883546830441\ \(0\)\
\-\ prior\\:\\ 0\\.0010120446366247064\ \(0\)\
\-\ both\\:\\ 0\\.0010065498112020856\ \(0\)\
\-\ over\\:\\ 0\\.0010035251799538573\ \(0\)\
\-\ with\\:\\ 0\\.0009714368863551731\ \(0\)\
\-\ increased\\:\\ 0\\.0009642457480625718\ \(0\)\
\-\ into\\:\\ 0\\.0009378811660330751\ \(0\)\
\-\ associated\\:\\ 0\\.0009301026577065045\ \(0\)\
\-\ most\\:\\ 0\\.0009099793089151642\ \(0\)\
\-\ small\\:\\ 0\\.0009080144300650916\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0009070351205410704\ \(0\)\
\-\ contrast\\:\\ 0\\.0008822766083062294\ \(0\)\
\-\ exam\\:\\ 0\\.0008658828136298608\ \(0\)\
\-\ lateral\\:\\ 0\\.0008517841538858627\ \(0\)\
\-\ \\-\\:\\ 0\\.0008448932005112378\ \(0\)\
\-\ female\\:\\ 0\\.0008103137783430967\ \(0\)\
\-\ old\\:\\ 0\\.0008071352369577995\ \(0\)\
\-\ mass\\:\\ 0\\.0005481831212857769\ \(0\)\
\-\ pain\\:\\ 0\\.000481369080964361\ \(0\)\
\-\ left\\:\\ 0\\.0004410079655317872\ \(0\)\
